Abstract

AbstractBackgroundApolipoprotein E ε4 allele (APOEε4) is considered the major genetic risk factor of Alzheimer´s Disease (AD). Structural magnetic resonance imaging (sMRI) studies demonstrated that, compared to APOEε4 non‐carriers, APOEε4 carriers display structural changes in lateral and medial temporal lobe (MTL). However, the knowledge about the impact of this genotype on hippocampal subfields is still limited. The present sMRI study aimed to evaluate volumetric and cortical thickness differences between adults with mild cognitive impairment (MCI) APOEε4 non‐carriers compared with MCI‐APOEε4 carriers.MethodTwelve MCI‐APOEε4 non‐carriers (mean age: 70.33 years, SD: 5.12) and ten MCI‐APOEε4 carriers (mean age: 72.70 years, SD: 6.38), diagnosed as MCI according Petersen criteria (Petersen, 2004; Albert et al., 2011), underwent neuropsychological assessment, cerebrospinal fluid, genetic and MRI examinations. MRI surface‐based morphometry analyses was conducted with the FreeSurfer software to evaluate volumetric and thickness differences in the hippocampal subfields and its surrounding MTL areas.ResultCompared with MCI‐APOEε4 non‐carriers, the MCI‐APOEε4 carriers group showed a significant reduced volume in several areas of the left hemisphere. Specifically, in this hemisphere volumetric changes were found in the entorhinal cortex, the whole hippocampus and in its head, body and tail; the head of presubiculum, the head and body of subiculum, the CA1, CA3, CA4 subfields, the granulate cell of the molecular layer of dentate gyrus and the molecular layer of the hippocampus. This group also displayed a significant reduced volume in the right body of CA3 subfield.ConclusionThese results suggest that, in MCI adults, the presence of the APOEε4 genotype may have an additional neuropathological impact on the structure of brain regions of the MTL with a critical functional role in episodic memory, the most affected neurocognitive system in Alzheimer’s disease (AD). Particularly, the left MTL would show higher vulnerability to neurodegenerative changes in the prodromal stage of AD.

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call